Scientists throughout the world, including in India, are concerned about 'Delta plus,' a developing form of the novel coronavirus's delta plus variant vaccine that permits it to "escape" antibodies in recently approved treatment regimens.

16 of the 22 cases of Delta Plus variant have been detected in Maharashtra, Kerala, and Madhya Pradesh, according to Union Health Secretary Rajesh Bhushan. The central government announced on Tuesday that two cases of the Delta Plus type had been discovered so far in the country. According to Union Health Secretary Rajesh Bhushan, 16 of the 22 cases were discovered in the Maharashtra towns of Ratnagiri and Jalgaon, as well as in Kerala and Madhya Pradesh. The delta plus variant vaccine type has also been detected in the United States, the United Kingdom, Portugal, Switzerland, Japan, Poland, Nepal, China, and Russia, according to Bhushan. The Delta version, on the other hand, has been found in 80 nations, according to him. However, Maharashtra Health Minister Rajesh Tope announced Wednesday that the state had discovered 21 cases of Covid-19's extremely pathogenic Delta Plus version. According to Tope, the maximum number of instances were reported in Ratnagiri, followed by seven in Jalgaon, two in Mumbai, and one each in Palghar, Thane, and Sindhudurg districts. A mutation in the Delta or B.1.617.2 variety, initially found in India and one of the drivers of the catastrophic second wave, has given rise to the new delta plus variant vaccine . Delta plus is purportedly resistant to the monoclonal antibody cocktail treatment for COVID-19 that was recently approved in India, albeit there is no evidence of the severity of the disease caused by the new version.